Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
System and method for order placement in an electronic trading environment
Server chassis
Method and apparatus for token-based context caching
Downhole telemetry system
Coordinate measuring device and method for measuring with a coordinate measuring device
Shipping container explosives and contraband detection system using nuclear quadrupole resonance
Inter-carrier communications for multimedia-message delivery
  Randomly Featured Patents
Fan blade
Clock signal fault detector
Advertising device
Dyeing method of dyeing plastic lens and dyeing device
Temperature-compensated control valve
Roll briquetting press
Apparatus and process for analysis of gaseous nitrogen trichloride
Digital arpeggio system
Method and apparatus for controlling sand accumulation in a producing wellbore
Apparatus and process for in-mold labeling